NEW YORK – The US National Institute of Neurological Disorders and Stroke (NINDS) has awarded Coriell Institute for Medical Research $7.7 million for ongoing support of its biorepository.
Under the terms of the five-year contract, Coriell will continue to support the NINDS Human Genetics Research Center. Camden, New Jersey-based Coriell has been the contractor for the NINDS center since its establishment in 2002.
NINDS' biorepository includes samples from subjects with various diseases, including cerebrovascular disease, dystonia, epilepsy, motor neuron disease, parkinsonism, and Tourette syndrome. It also collects demographic, clinical, and other genetic data, which it makes available to researchers globally.
According to Coriell, the new money will support sample processing as well as storage and distribution at the center, in addition to the expansion of resource sub-collections, such as those focused on cerebrovascular disease and dystonia.
The contract will also support work to link samples to genomic data stored in dbGAP, the database of National Institutes of Health Genotypes and Phenotypes.